- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01732601
Intensive Outpatient Services for Teens (INVEST)
January 21, 2018 updated by: Anthony Spirito, Brown University
Intensive Outpatient Protocol for High Risk Suicidal Teens
This study will identify the effectiveness of an intensive treatment program for teens who are at high risk for harming themselves.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Suicidal ideation and behavior are the primary reasons for emergency psychiatric care and inpatient psychiatric hospitalization in this country.
These expensive contacts with the health care system effectively address acute suicidality for many adolescents but there is a significant subset of suicidal patients that have continued suicidality.
This study will target teens that are at risk for re-hospitalization based on continued suicidal ideation, their mood and another risk factor such as self-harm or substance use.
These risk factors have been shown to increase risk for continued suicidal behavior and expensive contacts with the health care system.
This protocol has been designed to determine whether Intensive Cognitive Behavioral Therapy (CBT), which was designed to treat adolescents with a mood disorder, suicidal ideation, and substance use, will result in better treatment outcomes compared to standard care in the community.
The Intensive CBT condition will be delivered by a team of two licensed mental health therapists over the course of one year and will work with both the teen and parent.
The standard care condition will receive treatment in the community.
One hundred-and fifty adolescents (38 a year) will be recruited from several inpatient and partial hospital locations.
Each adolescent will receive a thorough baseline assessment to determine whether they are appropriate for the study and will be assigned to either the Intensive CBT condition or treatment within the community.
Both groups of teens will receive follow-up assessments at 6, 12, and 18 months to identify how they are doing over time.
Study Type
Interventional
Enrollment (Actual)
140
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02912
- Brown University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Current Mood Disorder and suicidal ideation and one of the following
- NSSI
- Suicide Attempt
- Substance Use
Exclusion Criteria:
- Intelligence Quotient < 80
- Diagnosis of psychotic disorder, pervasive developmental disorder, obsessive-compulsive disorder, bulimia nervosa or anorexia nervosa
- Adolescent use of illicit "hard" substances such as cocaine, heroine, and opiates 13 or more times over the prior 90 days
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intensive Outpatient CBT
Intensive CBT for both parents and adolescents as well as family sessions to increase communication.
|
Sessions will be delivered 1-2 times a week for the first 4-6 weeks, based on need, and then weekly until 6 months.
Therapy can continue up until one year.
Other Names:
|
|
Active Comparator: Standard Care
Standard Treatment in the Community
|
Treatment at step-down facilities
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Suicide attempts
Time Frame: Measured at 18 months from Baseline
|
Self-report by parents or teens of a suicide attempt occurring in the follow-up period
|
Measured at 18 months from Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depressed mood as assessed by the Children's Depression Rating Scale - Revised
Time Frame: Measured at 18 months from Baseline
|
Depressed mood as determined by clinical interview
|
Measured at 18 months from Baseline
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Other self harm behaviors including Nonsuicidal self-injury (NSSI) substance abuse
Time Frame: Measures 18 months from Baseline
|
Self report of behaviors considered self-harming including self-inflicted behaviors such as cutting with no suicidal intent or excessive substance use with negative consequences to the individual
|
Measures 18 months from Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2012
Primary Completion (Actual)
October 1, 2017
Study Completion (Actual)
January 1, 2018
Study Registration Dates
First Submitted
November 13, 2012
First Submitted That Met QC Criteria
November 19, 2012
First Posted (Estimate)
November 26, 2012
Study Record Updates
Last Update Posted (Actual)
January 23, 2018
Last Update Submitted That Met QC Criteria
January 21, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R01MH097703-01 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.